Cargando…

Immune Checkpoint Inhibition in Oesophago-Gastric Carcinoma

Immune checkpoint inhibitors enrich the therapeutic landscape in oesophago-gastric carcinoma. With regard to oesophageal squamous cell carcinoma (ESCC), the selective PD-1 (programmed cell death receptor 1)-inhibitor nivolumab improves disease-free survival in the adjuvant therapy setting (CHECKMATE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Högner, Anica, Thuss-Patience, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918118/ https://www.ncbi.nlm.nih.gov/pubmed/33673374 http://dx.doi.org/10.3390/ph14020151

Ejemplares similares

Immunotherapy in Gastric Cancer
por: Högner, Anica, et al.
Publicado: (2022)

Optimising Multimodality Treatment of Resectable Oesophago-Gastric Adenocarcinoma
por: Suwaidan, Ali Abdulnabi, et al.
Publicado: (2022)

Prognostic Relevance of Weight and Weight Loss during Multimodal Therapy for Oesophagogastric Tumours
por: Lorusso, Alessandro, et al.
Publicado: (2022)

The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction
por: Wayman, J, et al.
Publicado: (2002)

Neoadjuvant chemotherapy for carcinoma of the oesophagus and oesophago-gastric junction: a six-year experience
por: Halliday, Brian P, et al.
Publicado: (2007)

mRNA profiling of the cancer degradome in oesophago–gastric adenocarcinoma
por: Baren, J P, et al.
Publicado: (2012)

The Role of Mucin Expression in the Diagnosis of Oesophago-Gastric Cancer: A Systematic Literature Review
por: Patel, Nikhil Manish, et al.
Publicado: (2023)

Modified Oesophago-Gastric Dissociation (M-OGD) — a technical modification
por: Coletta, Riccardo, et al.
Publicado: (2020)

Propofol Sedation for Oesophago-Gastro-Duodenoscopy
por: Watt, J. M., et al.
Publicado: (1999)

Impact of Postoperative Chemotherapy in Patients with Gastric/Gastroesophageal Adenocarcinoma Treated with Perioperative Chemotherapy
por: Ballhausen, Alexej, et al.
Publicado: (2022)

Re-organisation of oesophago-gastric cancer care in England: progress and remaining challenges
por: Palser, Thomas R, et al.
Publicado: (2009)

Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma
por: De Silva, Nadeera, et al.
Publicado: (2015)

Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): The Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial
por: Lorenzen, Sylvie, et al.
Publicado: (2011)

A pooled analysis of molecularly targeted agents for treatment of metastatic oesophago-gastric cancer in elderly patients
por: Lv, Hui, et al.
Publicado: (2020)

Double stenting for malignant oesophago-respiratory fistula
por: Włodarczyk, Janusz, et al.
Publicado: (2016)

Psychosocial functioning in individuals with advanced oesophago-gastric cancer: a mixed methods systematic review
por: Ghiglieri, Cara, et al.
Publicado: (2023)

Immunotherapy in Squamous Cell Cancer of the Esophagus
por: Thuss-Patience, Peter, et al.
Publicado: (2022)

ASO Author Reflections: Applications of Artificial Intelligence in Oesophago-Gastric Malignancies—Present Work and Future Directions
por: Chidambaram, Swathikan, et al.
Publicado: (2021)

Evaluating the care received by patients with oesophago-gastric (OG) cancer: the richer picture provided by linked datasets
por: Brand, Christian, et al.
Publicado: (2017)

Feasibility of Implementation and the Impact of a Digital Prehabilitation Service in Patients Undergoing Treatment for Oesophago-Gastric Cancer
por: Moorthy, Krishna, et al.
Publicado: (2023)

The rare case of oesophago-pericardial fistula secondary to pulmonary tuberculosis
por: Sidhu, Kavina Kaur, et al.
Publicado: (2022)

Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer
por: Skipworth, R J E, et al.
Publicado: (2010)

Research protocol for a diagnostic study of non-invasive exhaled breath analysis for the prediction of oesophago-gastric cancer
por: Markar, Sheraz R, et al.
Publicado: (2016)

Volume-outcome revisited: The effect of hospital and surgeon volumes on multiple outcome measures in oesophago-gastric cancer surgery
por: Fischer, Claudia, et al.
Publicado: (2017)

Machine Learning for Risk Prediction of Oesophago-Gastric Cancer in Primary Care: Comparison with Existing Risk-Assessment Tools
por: Briggs, Emma, et al.
Publicado: (2022)

Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study
por: Roy, A, et al.
Publicado: (2012)

Evaluating the role of fluorodeoxyglucose positron emission tomography-computed tomography in multi-disciplinary team recommendations for oesophago-gastric cancer
por: Blencowe, N S, et al.
Publicado: (2013)

Re-organisation of oesophago-gastric cancer services in England and Wales: a follow-up assessment of progress and remaining challenges
por: Groene, Oliver, et al.
Publicado: (2014)

Main influencing factors and health-related quality of life issues in patients with oesophago-gastric cancer – as measured by EORTC tools
por: Tomaszewski, Krzysztof A., et al.
Publicado: (2013)

The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis
por: Chan, David L., et al.
Publicado: (2017)

ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)
por: Reynolds, JV, et al.
Publicado: (2017)

Understanding Potentially Preventable Mortality Following Oesophago-Gastric Cancer Surgery: Analysis of a National Audit of Surgical Mortality
por: Liu, David S., et al.
Publicado: (2023)

Immune checkpoint inhibition: prospects for prevention and therapy of hepatocellular carcinoma
por: Elsegood, Caryn L, et al.
Publicado: (2017)

Current Evidence for Immune Checkpoint Inhibition in Advanced Hepatocellular Carcinoma
por: Foy, Victoria, et al.
Publicado: (2023)

PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study
por: Obermannova, Radka, et al.
Publicado: (2022)

The risk of oesophago-gastric cancer in symptomatic patients in primary care: a large case–control study using electronic records
por: Stapley, S, et al.
Publicado: (2013)

Gastric Cancer in the Era of Immune Checkpoint Blockade
por: Figueroa-Protti, Lucía, et al.
Publicado: (2019)

Diagnosis and treatment for gastro-oesophageal cancer in England and Wales: analysis of the National Oesophago-Gastric Cancer Audit (NOGCA) database 2012–2020
por: Pucher, Philip H, et al.
Publicado: (2023)

Oesophageal squamous papilloma: a rare finding on oesophago-gastro-duodenoscopy with malignant potential
por: Li, Jia Xi Julian, et al.
Publicado: (2023)

Intersection of Two Checkpoints: Could Inhibiting the DNA Damage Response Checkpoint Rescue Immune Checkpoint-Refractory Cancer?
por: Goff, Peter H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lmnqvkqj86j9au7ah7ddq3ghhk